Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

CNH Board Announces Proposals To 2012 Annual General Meeting Of Shareholders

CNH Global N.V. (CNH: Quote) said that its board met February 16, 2012 to agree on recommendations for the company's 2012 Annual General Meeting of shareholders. The Board has set the meeting date as April 3, 2012.

The company said that at the board meeting, its board finalized proposals to be put to the Company's shareholders. Among the proposals was a recommendation that the shareholders re-elect the current directors and approve the appointment of a director candidate to the Board. The company stated that its board will recommend to the shareholders that the Company not declare a dividend in 2012.

The company noted that its Board also approved the CNH 2011 Statutory Accounts that will be presented to shareholders at the upcoming Annual General Meeting.

Click here to receive FREE breaking news email alerts for CNH Global NV and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.